Articles from AbTherx, Inc
AbTherx Licenses Atlas(TM) Platform to Athenova Therapeutics for Next-Generation Targeted Alpha Radiopharmaceutical Discovery
Partnership combines Atlas Mice with Athenova's novel oncology target and expertise in astatine-211-based therapies to accelerate new cancer treatments to the clinic
By AbTherx, Inc · Via ACCESS Newswire · November 18, 2026
